MindRhythm Seed

Employees ~10
Primary contact

MindRhythm is a brain wellness company that develops medical technology focused on preventing neurological injury, primarily caused by strokes. The company's proprietary monitoring devices and communication platform provide novel and real-time visibility to life-threatening situations prehospital and in the operating room allowing clinicians to intervene and prevent brain damage. Collaborating with the healthcare community, MindRhythm looks to apply the same systematic approach to reducing time to treatment in strokes that has been successfully implemented for heart attacks with the STEMI protocol.
Employees ~10
Primary contact

Funding πŸ’°

Total $5M
Last round πŸ”— August 24, 2021.
Select investors venBio Partners, DCVC, Aestus Capital, Perseverance Capital Management, Blue Fog Capital, Laman Ventures

Key people πŸ§‘β€πŸ€β€πŸ§‘

Highlights ⭐

  • Stroke is the 5th leading cause of death, with 800,000 strokes occurring each year (150,000 in the U.S. as of 2019). πŸ”—
  • MindRhythm aims to optimize stroke triage prehospital, speeding time to treatment and reducing morbidity and mortality in emergent stroke.
  • The company was founded by world-renowned experts with (important) significant commercialization experience.
  • The seed funding will allow MindRhythm to complete the clinical trial of its Harmony device and platform, demonstrating the effectiveness of the device in the EMS environment.
Last update: August 26, 2021